Business Standard

Jubilant Life Sciences receives final approval for Olmesartan Medoxomil Tablets

Image

Capital Market

From USFDA

Jubilant Life Sciences has received from USFDA Abbreviated New Drug Application final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 25 2017 | 11:08 AM IST

Explore News